SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-23-032870
Filing Date
2023-04-26
Accepted
2023-04-26 17:02:59
Documents
15
Period of Report
2023-02-09
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 8-K ea177331-8ka1_avalon.htm   iXBRL 8-K/A 42404
2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ea177331ex23-1_avalonglobo.htm EX-23.1 2172
3 AUDITED CONSOLIDATED FINANCIAL STATEMENTS OF LABORATORY SERVICES MSO FOR THE FIS ea177331ex99-1_avalonglobo.htm EX-99.1 238566
4 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION OF THE COMPANY AND ea177331ex99-2_avalonglobo.htm EX-99.2 445233
  Complete submission text file 0001213900-23-032870.txt   963584

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE albt-20230209.xsd EX-101.SCH 3251
6 XBRL LABEL FILE albt-20230209_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE albt-20230209_pre.xml EX-101.PRE 22375
9 EXTRACTED XBRL INSTANCE DOCUMENT ea177331-8ka1_avalon_htm.xml XML 4841
Mailing Address 4400 ROUTE 9 SUITE 3100 FREEHOLD NJ 07728
Business Address 4400 ROUTE 9 SUITE 3100 FREEHOLD NJ 07728 732-780-4400
Avalon GloboCare Corp. (Filer) CIK: 0001630212 (see all company filings)

IRS No.: 471685128 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-38728 | Film No.: 23850644
SIC: 2836 Biological Products, (No Diagnostic Substances)